These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 3987181

  • 1. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
    Vozeh S, Uematsu T, Guentert TW, Ha HR, Follath F.
    Clin Pharmacol Ther; 1985 May; 37(5):575-81. PubMed ID: 3987181
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
    Camsonne R, Moulin MA, Charbonneau P, Bazin C.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
    [Abstract] [Full Text] [Related]

  • 9. Method for stable measurement of the electrocardiogram in isolated guinea pig heart. Evaluation of the RR-QT relationship and the effect of quinidine.
    Uematsu T, Vozeh S, Ha HR, Follath F, Nakashima M.
    J Pharmacol Methods; 1987 Sep; 18(2):179-85. PubMed ID: 3626572
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S, Oti-Amoako K, Uematsu T, Follath F.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of quinidine on pharmacokinetics and pharmacodynamics of digitoxin achieving steady-state conditions.
    Kuhlmann J, Dohrmann M, Marcin S.
    Clin Pharmacol Ther; 1986 Mar; 39(3):288-94. PubMed ID: 3512148
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the pharmacokinetic and pharmacodynamic interaction between quinidine and nifedipine.
    Bowles SK, Reeves RA, Cardozo L, Edwards DJ.
    J Clin Pharmacol; 1993 Aug; 33(8):727-31. PubMed ID: 8408733
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assessment of quinidine gluconate for nonlinear kinetics following chronic dosing.
    Russo J, Russo ME, Smith RA, Pershing LK.
    J Clin Pharmacol; 1982 Aug; 22(5-6):264-70. PubMed ID: 7107973
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Concurrent use of quinidine and disopyramide: evaluation of serum concentrations and electrocardiographic effects.
    Baker BJ, Gammill J, Massengill J, Schubert E, Karin A, Doherty JE.
    Am Heart J; 1983 Jan; 105(1):12-5. PubMed ID: 6849225
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.